The S&P Emerging BMI captures all companies domiciled in the emerging markets within the S&P Global BMI with a float-adjusted market capitalization of at least USD 100 million and a minimum annual trading liquidity of USD 50 million. The index is segmented by country/region, size (large, mid and small), style (value and growth), and GICS (sectors/industry groups).
-1.31 -0.85% ▼
The S&P Pan Asia ex-JANZ Health Care 50 is designed to measure the 50 largest companies from the Global Industry Classification Standard (GICS®) ...
0.01 0% ▲
A member of the S&P Global BMI series, the S&P Developed BMI is a comprehensive benchmark including stocks from 25 developed markets.
-0.12 -0.05% ▼
A member of the S&P Global BMI series, the S&P Developed Ex-U.S. BMI is a comprehensive benchmark including stocks from developed markets excluding ...
-0.22 -0.09% ▼
A subset of the S&P Developed BMI, the S&P EPAC BMI provides investors exposure to the developed markets within the Europe and Asia Pacific regions.
0.21 0.04% ▲
The S&P U.S. BMI is a country sub-index of the S&P Global BMI, which includes all U.S. domiciled companies.
|SPDR S&P Emerging Markets ETF||ETF|
For Index Committee membership, including the chairperson and key contacts, please refer to the methodology.